Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares
Lloyd Price
FEBRUARY 18, 2024
2004: First GLP-1 receptor agonist (GLP-1 RA), exenatide, approved for type 2 diabetes treatment. Drug development: Pharmaceutical companies like Novo Nordisk, Eli Lilly, and AstraZeneca led the development and commercialization of GLP-1 RAs. 1996: Studies suggest GLP-1's potential in managing type 2 diabetes and obesity.
Let's personalize your content